Tofacitinib Represses the Janus Kinase-Signal Transducer and Activators of Transcription Signalling Pathway in Keratinocytes.
Sign Up to like & getrecommendations! Published in 2018 at "Acta dermato-venereologica"
DOI: 10.2340/00015555-2960
Abstract: Tofacitinib is a Janus kinase (JAK) inhibitor, which has shown efficacy in treating psoriasis. The mode of action of tofacitinib is not completely understood but it has been thought to be mediated by the inhibition… read more here.
Keywords: tofacitinib; signal transducer; activators transcription; transducer activators ... See more keywords